Biota Pharma (BOTA) Reports Q1 Loss of $0.17

Biota Pharma (NASDAQ: BOTA) reported Q1 EPS of ($0.17), versus ($0.20) reported last year. Revenue for the quarter came in at $1.7 million, versus $700 thousand reported last year.

For earnings history and earnings-related data on Biota Pharma (BOTA) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c